Source:http://linkedlifedata.com/resource/pubmed/id/21221513
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-19
|
pubmed:abstractText |
The p53 tumor suppressor exerts its function mainly as a transcriptional activator. Here we show that the Ras-related small GTPase Rad, an inhibitor of Rho kinase, is a direct transcriptional target of p53. Expression of Rad messenger RNA (mRNA) and protein was induced by DNA damage in a p53-dependent manner. The -2934/-2905-bp Rad promoter region, to which p53 bound, was required for p53-mediated Rad gene activation. Treatment by DNA damaging agents increased p53 occupancy and histone acetylation in the region of Rad promoter containing the p53-binding site. Expression of Rad diminished the inhibitory phosphorylation at Ser3 of cofilin, a regulator of actin dynamics, and suppressed migration and invasiveness of cancer cells. Knockdown of Rad promoted cell migration and alleviated the p53-mediated migration suppression. Frequent loss of Rad mRNA and protein expression was observed in non-small cell lung carcinoma tissues. Together our results reveal a mechanism that p53 may inhibit cell migration by disrupting actin dynamics via Rad activation and implicate a tumor suppressor role of Rad in lung cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1432-1440
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-92
|
pubmed:meshHeading |
pubmed-meshheading:21221513-Actin Depolymerizing Factors,
pubmed-meshheading:21221513-Blotting, Western,
pubmed-meshheading:21221513-Carcinoma,
pubmed-meshheading:21221513-Cell Line,
pubmed-meshheading:21221513-Cell Line, Tumor,
pubmed-meshheading:21221513-Cell Movement,
pubmed-meshheading:21221513-Chromatin Immunoprecipitation,
pubmed-meshheading:21221513-Electrophoretic Mobility Shift Assay,
pubmed-meshheading:21221513-Fluorescent Antibody Technique,
pubmed-meshheading:21221513-Humans,
pubmed-meshheading:21221513-Immunohistochemistry,
pubmed-meshheading:21221513-Lung Neoplasms,
pubmed-meshheading:21221513-Tumor Suppressor Protein p53,
pubmed-meshheading:21221513-ras Proteins
|
pubmed:year |
2011
|
pubmed:articleTitle |
Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells.
|
pubmed:affiliation |
Institute of Biochemistry and Molecular Biology, National Yang-Ming University, 155 Li-Nong St., Taipei 112, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|